S'abonner

Incidence Trends of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes in British Columbia, Canada - 20/05/20

Doi : 10.1016/j.jpeds.2020.02.069 
Kung-Ting Kao, MBChB, DMedSc 1, , Nazrul Islam, MBBS, MSc, MPH, PhD 2, , , Danya A. Fox, MD, MPH 1, Shazhan Amed, MD, MScPH 1,
1 Divisions of Diabetes and Endocrinology, British Columbia Children's Hospital and Department of Pediatrics, University of British Columbia, Vancouver, Canada 
2 MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK 

Reprint requests: Shazhan Amed, MD, MScPH, Endocrinology and Diabetes Unit, Room K4-212, British Columbia Children's Hospital, 4480 Oak Street, Vancouver BC V6H 3V4, Canada.Endocrinology and Diabetes UnitBritish Columbia Children's HospitalRoom K4-2124480 Oak StreetVancouverBCV6H 3V4Canada

Abstract

Objectives

To estimate the 11-year incidence trend of diabetic ketoacidosis (DKA) at and after the diagnosis of type 1 diabetes.

Study design

A retrospective cohort study using a population-based administrative cohort diagnosed with type 1 diabetes at <20 years of age from 2002 to 2012 in British Columbia, Canada. DKA at (1 episode per individual) and DKA after (multiple episodes per individual) the diagnosis of diabetes were defined as DKA occurring ≤14 days or >14 days, respectively, from diagnosis, identified using International Classification of Diseases, 9th and 10th editions codes. Incidence rate ratios were estimated using Poisson regression and DKA trends using Joinpoint regression analyses.

Results

There were 1519 individuals (mean age at first-DKA, 12.6 ± 5.9 years; 50% male) with ≥1 DKA episode identified. Of 2615 incident cases of type 1 diabetes, there were 847 (32.4%; mean age, 9.9 ± 4.8 years; 52% male) episodes of DKA at the diagnosis of diabetes. Among prevalent cases of type 1 diabetes (1790 cases in 2002 increasing to 2264 in 2012), there were 1886 episodes of DKA after the diagnosis of diabetes (mean age at first DKA, 15.7 ± 5.2 years). The rates per 100 person-years of DKA at diabetes diagnosis (ranging from 24.1 in 2008 to 37.3 in 2006) and DKA after diabetes diagnosis (ranging from 4.9 in 2002 to 7.7 in 2008) remained stable. Females showed a 67% higher rate of incidence of DKA after the diagnosis of diabetes compared with their male counterparts (incidence rate ratio, 1.67; 95% CI, 1.50-1.86; P < .001), adjusted for the temporal trend by fiscal year. Younger age at diagnosis (<5 years) was associated with a greater risk of DKA at the time of diabetes diagnosis and older children (≥10 years) had a greater risk of DKA after the diagnosis of diabetes.

Conclusions

The risk of DKA at the time of diagnosis of diabetes was greater with younger age and the risk of DKA after the diagnosis of diabetes was higher in females and older children and youth.

Le texte complet de cet article est disponible en PDF.

Keywords : type 1 diabetes, diabetic ketoacidosis, incidence, children, adolescents, pediatric

Abbreviations : APC, BC, DKA, ICD, IRR


Plan


 Funded by Diabetes Canada (formerly Canadian Diabetes Association) (OG- 3-14-4488-SA). All inferences, opinions, and conclusions drawn in this article are those of the authors, and do not reflect the opinions or policies of the Population Data BC's Data Steward(s). The authors declare no conflicts of interest.
 Portions of this study were presented at the American Diabetes Association Scientific Sessions, June 7-11, 2019, San Francisco, CA.


© 2020  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 221

P. 165 - juin 2020 Retour au numéro
Article précédent Article précédent
  • Youth Perspectives of Prescription Pain Medication in the Opioid Crisis
  • Calista M. Harbaugh, Joceline V. Vu, Melissa DeJonckheere, Noa Kim, Lauren P. Nichols, Tammy Chang
| Article suivant Article suivant
  • Associations Between Early Low-Level Tobacco Smoke Exposure and Executive Function at Age 8 Years
  • Karin Oh, Yingying Xu, Brandon F. Terrizzi, Bruce Lanphear, Aimin Chen, Amy E. Kalkbrenner, Kimberly Yolton

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.